Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Envoy Medical (COCH) Depreciation & Amortization (CF) (2022 - 2025)

Envoy Medical's Depreciation & Amortization (CF) history spans 4 years, with the latest figure at $80000.0 for Q4 2025.

  • Quarterly results put Depreciation & Amortization (CF) at $80000.0 for Q4 2025, up 66.67% from a year ago — trailing twelve months through Dec 2025 was $317000.0 (up 37.23% YoY), and the annual figure for FY2025 was $302000.0, up 74.57%.
  • Depreciation & Amortization (CF) for Q4 2025 was $80000.0 at Envoy Medical, up from $76000.0 in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $100000.0 in Q2 2024 to a low of $26000.0 in Q4 2022.
  • The 4-year median for Depreciation & Amortization (CF) is $48000.0 (2023), against an average of $54384.6.
  • Peak annual rise in Depreciation & Amortization (CF) hit 244.83% in 2024, while the deepest fall reached 0.0% in 2024.
  • Year by year, Depreciation & Amortization (CF) stood at $26000.0 in 2022, then skyrocketed by 84.62% to $48000.0 in 2023, then changed by 0.0% to $48000.0 in 2024, then skyrocketed by 66.67% to $80000.0 in 2025.
  • According to Business Quant data, Depreciation & Amortization (CF) over the past three periods came in at $80000.0, $76000.0, and $100000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.